Breaking: Vinay Prasad returns to the FDA, weeks after ouster

He will resume his role overseeing vaccine, gene therapy, and blood product regulation

Log In    Subscribe BREAKING NEWS   Vinay Prasad returns to the FDA, weeks after ouster By Lizzy Lawrence Courtesy FDA Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine, gene therapy, and blood product regulation, according to a spokesman for the Department of Health and Human Services.   It is not clear whether he will also still serve as the FDA's chief medical and scientific officer.   Prasad left the agency a mere two weeks ago, after escalating tensions related to a gene therapy product for Duchenne's muscular dystrophy made by Sarepta Therapeutics and a campaign criticizing Prasad's politics launched by right-wing influencer Laura Loomer.  READ MORE Sign up for Daily Recap All the health and medical news you need today, in one email. Learn more. In Case You Missed It At town hall, FDA employees raise concerns about staffing, impromptu expert meetings By Lizzy Lawrence Inside the fall of Vinay Prasad at the FDA By Lizzy Lawrence FDA publishes rejection letters sent to drugmakers, with a big caveat By Andrew Joseph and Lizzy Lawrence As mRNA falls out of favor for HHS, are cancer vaccines next? By Angus Chen, Megan Molteni, and Marissa Russo Don't miss out on another STAT investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us